Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

New Process to Create Artificial Cell Membranes Developed

By BiotechDaily International staff writers
Posted on 17 Oct 2013
Image: Quantitative deposition of lipid monolayers yielded vesicles with fluorescence variance in agreement with model predictions (Photo courtesy of Scripps Research Institute, via Nature Chemistry).
Image: Quantitative deposition of lipid monolayers yielded vesicles with fluorescence variance in agreement with model predictions (Photo courtesy of Scripps Research Institute, via Nature Chemistry).
Scientists have developed a highly programmable and controlled platform for preparing and experimentally studying synthetic cell-like membrane-enclosed structures.

Understanding the myriad biochemical roles of membranes surrounding cells and inside them requires the ability to prepare realistic synthetic versions of these complex multilayered structures, a long-standing challenge. In a study published in the journal Nature Chemistry, online September 29, 2013, scientists at The Scripps Research Institute (TSRI; Jupiter, FL, USA) describe an innovative method they have developed for studying cell-like membrane-enclosed vesicles—layer-by-layer phospholipid membrane assembly on microfluidic droplets, a route to structures with defined compositional asymmetry and lamellarity.

Starting with a technique commonly used to deposit molecules on a solid surface, Langmuir-Blodgett deposition, the scientists repurposed the approach to work on liquid objects. They engineered a microfluidic device containing an immobilized array of microscopic cups, each trapping a single droplet of water bathed in oil and lipids. The arrayed trapped droplets are then ready to serve as a foundation for building up a series of lipid layers like coats of paint. “Layer-by-layer membrane assembly allows us to create synthetic cells with membranes of arbitrary complexity at the molecular and supramolecular scale,” said TSRI Assistant Professor Brian Paegel, who authored the study with Research Associate Sandro Matosevic; “We can now control the molecular composition of the inner and outer layers of a bilayer membrane, and even assemble multilayered membranes that resemble the envelope of the cell nucleus.”

The lipid-coated water droplets are first bathed in water. As the water/oil interface encounters the trapped droplets, a second lipid layer coats the droplets and transforms them into unilamellar vesicles. Bathing the vesicles in oil/lipid deposits a third lipid layer, which is followed by deposition of a final layer of lipids. The final product after these three phase exchanges is an immobilized array of double-bilayer vesicles.

“The computer-controlled microfluidic circuits we have constructed will allow us to assemble synthetic cells not only from biologically derived lipids, but from any amphiphile and to measure important chemical and physical parameters, such as permeability and stability,” said Prof. Paegel.

Related Links:
The Scripps Research Institute




comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Illustration of the apoER2 receptor protein shows the structure of the entire protein in detail (Photo courtesy of Wikimedia Commons).

Risk of Cardiovascular Disease Linked to Apolipoprotein E Variants

The apoE4 variant form of circulating apolipoprotein E (apoE) leads to increased risk of cardiovascular disease by blocking binding of the normal apoE3 form to the apoliprotein E receptor 2 (apoER2) in... Read more

Drug Discovery

view channel
Image: S-649266 has more robust antibacterial activity than established antibiotics against multidrug-resistant bacteria (Photo courtesy of Shionogi).

Novel Antibiotic Shows Potential for Broad Range of Infections

The emergence of bacterial resistance to known antibacterial agents is becoming a major challenge in treating the infection caused by multi drug resistant (MDR) bacteria. In order to treat bacterial... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.